calquence hard capsules 100mg
astrazeneca singapore pte ltd - acalabrutinib - capsule - acalabrutinib 100mg
calquence hard capsules 100mg
astrazeneca sdn. bhd. - acalabrutinib -
tremelimumab astrazeneca
astrazeneca ab - tremelimumab - carcinoma, non-small-cell lung - antineoplastic agents - tremelimumab astrazeneca in combination with durvalumab and platinum-based chemotherapy is indicated for the first-line treatment of adults with metastatic non-small cell lung cancer (nsclc) with no sensitising egfr mutations or alk positive mutations.
calquence tablet
astrazeneca canada inc - acalabrutinib (acalabrutinib maleate) - tablet - 100mg - acalabrutinib (acalabrutinib maleate) 100mg
astrazeneca water for injections 10ml ampoule
astrazeneca pty ltd - water for injections -
astrazeneca water for injections 5ml ampoule
astrazeneca pty ltd - water for injections -
astrazeneca sodium chloride 0.9% 10ml injection bpampoule
astrazeneca pty ltd - sodium chloride -
astrazeneca sodium chloride 0.9% 5ml injection bp ampoule
astrazeneca pty ltd - sodium chloride -
calquence 100mg cápsulas
astrazeneca pharmaceuticals lp - acalabrutinib - acalabrutinib....100.00 mg.
pandemic influenza vaccine h5n1 astrazeneca (previously pandemic influenza vaccine h5n1 medimmune)
astrazeneca ab - reassortant influenza virus (live attenuated) of the following strain: a/vietnam/1203/2004 (h5n1) strain - influenza, human - vaccines - prophylaxis of influenza in an officially declared pandemic situation in children and adolescents from 12 months to less than 18 years of age.pandemic influenza vaccine h5n1 astrazeneca should be used in accordance with official guidance